GLINTA PLUS 25 mg+5MG TABLET contains Empagliflozin 25 mg + Linagliptin 5 mg. It is a combination antidiabetic medicine (SGLT2 inhibitor + DPP-4 inhibitor) used for the treatment of type 2 diabetes mellitus to improve blood glucose control.
Uses:
Treatment of type 2 diabetes mellitus
Improves blood glucose control along with diet and exercise
Used when a combination of Empagliflozin and Linagliptin is appropriate
Helps reduce the risk of diabetes-related complications by maintaining blood glucose levels
Dose:
Usually one tablet once daily, or as prescribed by the physician
Preferably taken in the morning, with or without food
Take the tablet at the same time each day
Dose and duration should be adjusted according to the patient's condition and response to treatment